These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2998276)

  • 1. Topical butylated hydroxytoluene treatment of genital herpes simplex virus infections of guinea pigs.
    Richards JT; Katz ME; Kern ER
    Antiviral Res; 1985 Oct; 5(5):281-90. PubMed ID: 2998276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of recurrent herpes simplex labialis with topical butylated hydroxytoluene.
    Freeman DJ; Wenerstrom G; Spruance SL
    Clin Pharmacol Ther; 1985 Jul; 38(1):56-9. PubMed ID: 2988845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyclovir treatment of experimental genital herpes simplex virus infections.
    Kern ER
    Am J Med; 1982 Jul; 73(1A):100-8. PubMed ID: 6285699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of HPMPC therapy for primary and recurrent genital herpes in mice and guinea pigs.
    Bravo FJ; Stanberry LR; Kier AB; Vogt PE; Kern ER
    Antiviral Res; 1993 May; 21(1):59-72. PubMed ID: 8391249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of 2-deoxy-D-glucose in the treatment of experimental cutaneous and genital infections due to herpes simplex virus.
    Kern ER; Glasgow LA; Klein RJ; Friedman-Kien AE
    J Infect Dis; 1982 Aug; 146(2):159-66. PubMed ID: 6286785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and guinea pigs.
    Richards JT; Kern ER; Overall JC; Glasgow LA
    Antiviral Res; 1982 May; 2(1-2):27-39. PubMed ID: 6179469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical SMIP-7.7, a toll-like receptor 7 agonist, protects against genital herpes simplex virus type-2 disease in the guinea pig model of genital herpes.
    Bernstein DI; Cardin RD; Bravo FJ; Earwood J; Clark JR; Li Y; Mishra P; Li C; Nayak BP; Miller AT; Wu TY; Cooke MP; Valiante NM
    Antivir Chem Chemother; 2014 Apr; 23(5):189-96. PubMed ID: 23232327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the herpes simplex virus antiviral activity of pyrethrins.
    Stanberry LR; Bernstein DI; Myers MG
    Antiviral Res; 1986 Mar; 6(2):95-102. PubMed ID: 3010859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir treatment of experimental genital herpes simplex virus infections. I. Topical therapy of type 2 and type 1 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1983 Nov; 3(4):253-67. PubMed ID: 6320718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod.
    Miller RL; Imbertson LM; Reiter MJ; Gerster JF
    Antiviral Res; 1999 Nov; 44(1):31-42. PubMed ID: 10588331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antioxidant healing formulations in topical therapy of experimental cutaneous and genital herpes simplex virus infections.
    Sheridan J; Kern E; Martin A; Booth A
    Antiviral Res; 1997 Dec; 36(3):157-66. PubMed ID: 9477116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections.
    Corey L; Benedetti JK; Critchlow CW; Remington MR; Winter CA; Fahnlander AL; Smith K; Salter DL; Keeney RE; Davis LG; Hintz MA; Connor JD; Holmes KK
    Am J Med; 1982 Jul; 73(1A):326-34. PubMed ID: 7048919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial of topical acyclovir in genital herpes simplex virus infections.
    Corey L; Nahmias AJ; Guinan ME; Benedetti JK; Critchlow CW; Holmes KK
    N Engl J Med; 1982 Jun; 306(22):1313-9. PubMed ID: 6280052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemorrhages due to defective blood coagulation do not occur in mice and guinea-pigs fed butylated hydroxytoluene, but nephrotoxicity is found in mice.
    Takahashi O
    Food Chem Toxicol; 1992 Feb; 30(2):89-97. PubMed ID: 1555799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prodrugs of 9-beta-D-arabinofuranosyladenine for therapeutic efficacy in the topical treatment of genital herpesvirus infections in guinea pigs.
    Shannon WM; Arnett G; Baker DC; Kumar SD; Higuchi WI
    Antimicrob Agents Chemother; 1983 Nov; 24(5):706-12. PubMed ID: 6686429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acyclovir on genital herpes in guinea pigs.
    Pronovost AD; Lucia HL; Dann PR; Hsiung GD
    J Infect Dis; 1982 Jun; 145(6):904-8. PubMed ID: 6282986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent genital herpes simplex virus infection in guinea pigs.
    Stanberry LR; Kern ER; Richards JT; Overall JC
    Intervirology; 1985; 24(4):226-31. PubMed ID: 3000982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection.
    Pyles RB; Higgins D; Chalk C; Zalar A; Eiden J; Brown C; Van Nest G; Stanberry LR
    J Virol; 2002 Nov; 76(22):11387-96. PubMed ID: 12388699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acyclovir on genital infection with herpes simplex virus types 1 and 2 in the guinea pig.
    Landry ML; Lucia HL; Hsiung GD; Pronovost AD; Dann PR; August MJ; Mayo DR
    Am J Med; 1982 Jul; 73(1A):143-50. PubMed ID: 6285705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.